These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

823 related articles for article (PubMed ID: 17543579)

  • 1. Validation of the Augmentation Severity Rating Scale (ASRS): a multicentric, prospective study with levodopa on restless legs syndrome.
    García-Borreguero D; Kohnen R; Högl B; Ferini-Strambi L; Hadjigeorgiou GM; Hornyak M; de Weerd AW; Happe S; Stiasny-Kolster K; Gschliesser V; Egatz R; Cabrero B; Frauscher B; Trenkwalder C; Hening WA; Allen RP
    Sleep Med; 2007 Aug; 8(5):455-63. PubMed ID: 17543579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Translation and validation of a French version of the Young Mania Rating Scale (YMRS)].
    Favre S; Aubry JM; Gex-Fabry M; Ragama-Pardos E; McQuillan A; Bertschy G
    Encephale; 2003; 29(6):499-505. PubMed ID: 15029084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychometric evaluation and tests of validity of the Medical Outcomes Study 12-item Sleep Scale (MOS sleep).
    Allen RP; Kosinski M; Hill-Zabala CE; Calloway MO
    Sleep Med; 2009 May; 10(5):531-9. PubMed ID: 18805054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One-year treatment with standard and sustained-release levodopa: appropriate long-term treatment of restless legs syndrome?
    Trenkwalder C; Collado Seidel V; Kazenwadel J; Wetter TC; Oertel W; Selzer R; Kohnen R
    Mov Disord; 2003 Oct; 18(10):1184-9. PubMed ID: 14534925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The reliability, validity and responsiveness of the International Restless Legs Syndrome Study Group rating scale and subscales in a clinical-trial setting.
    Abetz L; Arbuckle R; Allen RP; Garcia-Borreguero D; Hening W; Walters AS; Mavraki E; Kirsch JM
    Sleep Med; 2006 Jun; 7(4):340-9. PubMed ID: 16713344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerability of ropinirole in patients with restless legs syndrome and a baseline IRLS total score > or = 24 points--data from the ropinirole clinical trial programme.
    Giorgi L; Ritchie SY; Kirsch JM
    Curr Med Res Opin; 2006 Oct; 22(10):1867-77. PubMed ID: 17022844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The severity range of restless legs syndrome (RLS) and augmentation in a prospective patient cohort: association with ferritin levels.
    Frauscher B; Gschliesser V; Brandauer E; El-Demerdash E; Kaneider M; Rücker L; Poewe W; Högl B
    Sleep Med; 2009 Jun; 10(6):611-5. PubMed ID: 19200780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Translation and validation of restless leg syndrome quality of life questionnaire in Hindi language.
    Vishwakarma K; Lahan V; Gupta R; Goel D; Dhasmana DC; Sharma T; Kalra J
    Neurol India; 2012; 60(5):476-80. PubMed ID: 23135023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RLS assessment and sleep questionnaires in practice--lessons learned from Parkinson's disease.
    Högl B; Gschliesser V
    Sleep Med; 2007 Aug; 8 Suppl 2():S7-12. PubMed ID: 17567533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ropinirole in patients with restless legs syndrome and baseline IRLS total scores ≥ 24: efficacy and tolerability in a 26-week, double-blind, parallel-group, placebo-controlled study followed by a 40-week open-label extension.
    Giorgi L; Asgharian A; Hunter B
    Clin Ther; 2013 Sep; 35(9):1321-36. PubMed ID: 23938061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a multidimensional measure for recurrent abdominal pain in children: population-based studies in three settings.
    Malaty HM; Abudayyeh S; O'Malley KJ; Wilsey MJ; Fraley K; Gilger MA; Hollier D; Graham DY; Rabeneck L
    Pediatrics; 2005 Feb; 115(2):e210-5. PubMed ID: 15687428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of pramipexole in restless legs syndrome: a six-week, multicenter, randomized, double-blind study (effect-RLS study).
    Oertel WH; Stiasny-Kolster K; Bergtholdt B; Hallström Y; Albo J; Leissner L; Schindler T; Koester J; Reess J;
    Mov Disord; 2007 Jan; 22(2):213-9. PubMed ID: 17133582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic standards for dopaminergic augmentation of restless legs syndrome: report from a World Association of Sleep Medicine-International Restless Legs Syndrome Study Group consensus conference at the Max Planck Institute.
    García-Borreguero D; Allen RP; Kohnen R; Högl B; Trenkwalder C; Oertel W; Hening WA; Paulus W; Rye D; Walters A; Winkelmann J; Earley CJ;
    Sleep Med; 2007 Aug; 8(5):520-30. PubMed ID: 17544323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of restless legs syndrome--methodological approaches for use in practice and clinical trials.
    Kohnen R; Allen RP; Benes H; Garcia-Borreguero D; Hening WA; Stiasny-Kolster K; Zucconi M
    Mov Disord; 2007; 22 Suppl 18():S485-94. PubMed ID: 17534967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced external counter pulsation (EECP) as a novel treatment for restless legs syndrome (RLS): a preliminary test of the vascular neurologic hypothesis for RLS.
    Rajaram SS; Shanahan J; Ash C; Walters AS; Weisfogel G
    Sleep Med; 2005 Mar; 6(2):101-6. PubMed ID: 15716213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of the French version of the arthritis impact measurement scales 2 and comparison with the french version of the Nottingham Health Profile. "Quality of Life in Rheumatology" Task Force.
    Pouchot J; Guillemin F; Coste J; Brégeon C; Sany J
    Rev Rhum Engl Ed; 1996 Jun; 63(6):389-404. PubMed ID: 8817749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cabergoline compared to levodopa in the treatment of patients with severe restless legs syndrome: results from a multi-center, randomized, active controlled trial.
    Trenkwalder C; Benes H; Grote L; Happe S; Högl B; Mathis J; Saletu-Zyhlarz GM; Kohnen R;
    Mov Disord; 2007 Apr; 22(5):696-703. PubMed ID: 17274039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a 32-item scale to assess postoperative dysfunction after upper gastrointestinal cancer resection.
    Nakamura M; Kido Y; Egawa T
    J Clin Nurs; 2008 Jun; 17(11):1440-9. PubMed ID: 18482141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transdermal lisuride: short-term efficacy and tolerability study in patients with severe restless legs syndrome.
    Benes H
    Sleep Med; 2006 Jan; 7(1):31-5. PubMed ID: 16194624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose pramipexole in the management of restless legs syndrome. An open label trial.
    Stiasny-Kolster K; Oertel WH
    Neuropsychobiology; 2004; 50(1):65-70. PubMed ID: 15179023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.